tiprankstipranks
Xilio Therapeutics (XLO)
NASDAQ:XLO
US Market

Xilio Therapeutics (XLO) Cash flow

Compare
156 Followers

Xilio Therapeutics Cash Flow

XLO's free cash flow for Q4 2024 was $-14.16M. For the 2024 fiscal year, XLO's free cash flow was decreased by $-18.34M and operating cash flow was $-14.16M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -18.38M$ -68.62M$ -75.72M$ -80.75M$ -36.09M
Investing Cash Flow
$ -36.00K$ -486.00K$ -1.87M$ -1.10M$ -2.19M
Financing Cash Flow
$ 29.20M$ -6.55M$ -69.00K$ 260.67M$ 10.03M
End Cash Position
$ 57.07M$ 46.29K$ 121.95M$ 199.61M$ 20.79M
Free Cash Flow
$ -18.41M$ -69.11K$ -77.59M$ -81.85M$ -38.28M
Currency in USD

Xilio Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis